The three new rechargeable models of the new Jabra Enhance Select M Series product line: the M3, M2, and M1. Jabra Enhance is replacing its existing over-the-counter (OTC) hearing aid lineup with three new, updated, FDA-cleared self-fitting models: the Enhance Select M3, M2, and M1 ....
Continue reading at Hearing Tracker
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable clinical change; this is a product launch announcement with no comparative effectiveness data versus existing OTC or prescription devices.
The M Series expands the OTC hearing aid market with a tiered rechargeable lineup, increasing consumer choice and potentially drawing more price-sensitive patients away from clinic-dispensed devices.
- 01Jabra Enhance M Series includes three models: M3, M2, and M1, replacing the existing OTC lineup.
- 02All models are FDA-cleared for self-fitting over-the-counter use.
- 03Devices are rechargeable, targeting convenience-focused consumers.
- 04Launch represents a portfolio refresh, not an entirely new product category for Jabra.
- 05No independent clinical performance data accompany the announcement.
The M Series hearing aids are FDA-cleared for OTC self-fitting use.
press releasesupportedThe M Series replaces Jabra Enhance's existing over-the-counter hearing aid lineup.
press releasesupported